Previous 10 | Next 10 |
2023-03-28 08:31:04 ET Monopar Therapeutics MNPR -50% as Validive program gets axed after trial failure . WiSA Technologies WISA -28% after proposes securities offering . OncoSec Medical ( ONCS ) -25% . Allarity Therapeutics ALLR -18% amid enr...
2023-03-28 07:06:22 ET Allarity Therapeutics ( NASDAQ: ALLR ) said it is working towards accelerating patient recruitment in ongoing phase 2 trials of Ixempra and stenoparib as monotherapies for cancer. The company expects interim data readouts by the end of 2023. H...
Efforts underway to accelerate patient recruitment and a mend protocols to improve patient outcomes . I nterim data readouts for both studies anticipated in H2 2023 . Press release BOSTON — March ...
2023-03-27 08:52:49 ET First Citizens BancShares ( FCNCA ) +39% deal for First Citizens to buy Silicon Valley Bank. First Republic Bank ( FRC ) +24% inks deal for First Citizens to buy Silicon Valley Bank. Baudax ( BXRX ) +26% Announces Posi...
2023-03-24 10:35:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Block (NYSE: SQ ) stock is a hot topic among traders on Friday after the company was targeted in a Hindenburg Research short report. That report had Hindenburg calling o...
2023-03-24 09:38:38 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Deutsche Bank (NYSE: DB ) stock is falling on Friday as credit default swaps hammer the banking company’s shares. The big news here is the company’s five-year ...
2023-03-24 09:15:09 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Allarity Therapeutics (NASDAQ: ALLR ) stock is sliding lower on Friday after announcing a reverse stock split . According to a press release, the company plans to enact ...
2023-03-24 06:54:17 ET Allarity Therapeutics ( NASDAQ: ALLR ) plans to undertake a 1-for-35 reverse stock split, effective post market on March 24. The company's common stock will begin trading on a post split-adjusted basis on March 27. The reverse stock split is bein...
Common Stock Will Begin Trading on a Post-Split Adjusted Basis on March 27, 2023 Press release BOSTON, Mass - March 24, 2023 — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company d...
2023-03-21 06:00:00 ET 3 Methods to Use for Investing in Penny Stocks Penny stocks present a distinctive and frequently undervalued prospect for investors who seek high-yield investments in the small-cap sector. These affordably priced stocks, usually sold for under $5 per share, offer ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
7.99%Change Percent:
Allarity Therapeutics Inc. Company Name:
ALLR Stock Symbol:
NASDAQ Market:
Allarity Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Boston (July 24, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, encourages its stockholders to participate actively in the ...
Current Cash Balance of $20 million Expected to Provide Runway Into 2026 Allarity to Pause Use of ATM Cap Table Successfully Cleaned Up Allarity’s Stenoparib Shows Extended Duration of Phase 2 Clinical Benefit Boston (July 22, 2024)—Allarity The...